Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
170.3 USD | +0.21% |
|
+1.80% | +9.87% |
Jul. 12 | AbbVie Submits FDA, EMA Applications for Upadacitinib to Treat Giant Cell Arteritis | MT |
Jul. 12 | AbbVie Seeks U.S., Europe OK of Rinvoq in Giant Cell Arteritis | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.87% | 300B | |
+62.66% | 841B | |
+40.42% | 625B | |
-4.37% | 360B | |
+17.16% | 327B | |
+15.66% | 242B | |
+17.90% | 227B | |
+14.86% | 174B | |
+0.45% | 162B | |
+5.17% | 127B |
- Stock Market
- Equities
- ABBV Stock
- News AbbVie Inc.
- AbbVie Plans $13 Billion Bond Sale to Fund Acquisitions